
Sign up to save your podcasts
Or


Henrietta Lacks died in 1951 from a virulent cervical cancer. A sample of those cancer cells was taken at the time, and the way they behave has changed medical science forever, contributing to everything from the polio vaccine to drugs for Parkinson’s and Alzheimer’s disease. As the WHO give a posthumous award, Claudia discusses how the Henrietta Lacks legacy raises issues of global health equity.
Plus with a Malaria Vaccine given a historic green light by the WHO to protect children in Africa, what are the distribution difficulties in countries which carry the greatest burden of disease?
And what’s behind the low rate of Covid-19 vaccinations in Taiwan? We hear from one resident about why she’s chosen to have a home-grown Medigen vaccine which hasn’t yet completed all its clinical trials – and another who wants to wait for an alternative. Scientists say that trials about to start in Paraguay should show whether it stimulates enough immunity to protect people in the way the AstraZeneca vaccine does.
Presenter: Claudia Hammond
(Picture: Henrietta Lacks, after whom HeLa cells are named, standing outside her home in Baltimore, USA. Photo credit: Getty Images.)
By BBC World Service4.7
7979 ratings
Henrietta Lacks died in 1951 from a virulent cervical cancer. A sample of those cancer cells was taken at the time, and the way they behave has changed medical science forever, contributing to everything from the polio vaccine to drugs for Parkinson’s and Alzheimer’s disease. As the WHO give a posthumous award, Claudia discusses how the Henrietta Lacks legacy raises issues of global health equity.
Plus with a Malaria Vaccine given a historic green light by the WHO to protect children in Africa, what are the distribution difficulties in countries which carry the greatest burden of disease?
And what’s behind the low rate of Covid-19 vaccinations in Taiwan? We hear from one resident about why she’s chosen to have a home-grown Medigen vaccine which hasn’t yet completed all its clinical trials – and another who wants to wait for an alternative. Scientists say that trials about to start in Paraguay should show whether it stimulates enough immunity to protect people in the way the AstraZeneca vaccine does.
Presenter: Claudia Hammond
(Picture: Henrietta Lacks, after whom HeLa cells are named, standing outside her home in Baltimore, USA. Photo credit: Getty Images.)

7,732 Listeners

881 Listeners

1,037 Listeners

5,513 Listeners

1,814 Listeners

1,830 Listeners

1,075 Listeners

772 Listeners

267 Listeners

346 Listeners

961 Listeners

436 Listeners

417 Listeners

84 Listeners

249 Listeners

354 Listeners

352 Listeners

85 Listeners

134 Listeners

476 Listeners

142 Listeners

3,162 Listeners

757 Listeners

1,635 Listeners